Published in Health and Medicine Week, May 23rd, 2005
Jeff Randall has been named CFO, Gary Floyd has been named vice president of operations, and John Bennett has been named vice president of business development. The announcement came 1 week after the company disclosed the completion of enrollment in its pivotal phase III clinical study with THYMITAQ (nolatrexed), an investigational product, for the treatment of inoperable primary liver cancer (hepatocellular carcinoma).
Jeff Randall brings over 20 years of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.